The burden of out-of-pocket and indirect costs of prostate cancer

The Prostate
Ravishankar JayadevappaS Bruce Malkowicz

Abstract

Out-of-pocket and indirect (OPI) costs play an important role in prostate cancer (PCa) outcomes research. We sought to analyze OPI costs of newly diagnosed PCa patients receiving either radical prostatectomy (RP) or external beam radiation therapy (EBRT). Prospective cohort design was used to recruit 512 newly diagnosed PCa patients from urology clinics of an urban academic hospital and a Veterans Administration medical center. Participants provided demographic information and completed self-reported generic and prostate-specific Health Related Quality of Life (HRQoL) and indirect-cost surveys at baseline and at 3, 6, 12, and 24 months follow-up. Linear mixed models were applied to study the association between OPI costs, treatment and HRQoL outcomes. Propensity scores adjusted for potential confounders and Bonferroni correction was used to account for multiple testing. Total mean OPI costs varied between RP group and EBRT group at 3-month ($5576 vs. $2010), 6-month ($1776 vs. $2133), 12-month ($757 vs. $774), and at 24-month follow-up ($458 vs. $871). Linear mixed models indicated that RP was associated with lower medication costs (OR = 0.61, CI = 0.48-0.89) and total OPI costs (OR = 0.71, CI = 0.64-0.92). Total OPI costs were...Continue Reading

References

Aug 1, 1997·The Journal of Arthroplasty·A Diwan, R Drummond
Nov 1, 1994·Health Economics·M A Koopmanschap, F F Rutten
Jan 14, 1999·International Journal of Technology Assessment in Health Care·P Jacobs, K Fassbender
Apr 27, 1999·Medical Care·P G Barnett
May 2, 2001·International Journal of Technology Assessment in Health Care·T I ShiremanS J Goldie
Jul 13, 2002·Cancer·Wendy MaxXiulan Zhang
Oct 22, 2003·Journal of Clinical Epidemiology·Jean Mundahl Engels, Paula Diehr
Oct 27, 2004·Journal of the National Cancer Institute. Monographs·Dennis G Fryback, Benjamin M Craig
Jul 7, 2005·Journal of the National Cancer Institute·Cathy J BradleyMaryjean Schenk
Jan 11, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Neal J Meropol, Kevin A Schulman
Jan 11, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel P Sulmasy
Jan 11, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paula Kim
Feb 22, 2008·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Jul 4, 2008·CA: a Cancer Journal for Clinicians·Ya-Chen Tina Shih, Michael T Halpern

❮ Previous
Next ❯

Citations

Mar 6, 2012·Journal of Cancer Survivorship : Research and Practice·Catherine C LerroKatherine S Virgo
Jul 10, 2014·Journal of the National Cancer Institute·Ronald C ChenHoward M Sandler
Jun 3, 2015·Neuro-oncology Practice·Priya KumthekarJeffrey J Raizer
Apr 3, 2015·Acta Oncologica·Saku TorvinenKimmo Taari
Oct 30, 2012·Urology·Olivia S JungJustin E Bekelman
Aug 27, 2013·Journal of Cancer Survivorship : Research and Practice·Claire de OliveiraMurray D Krahn
Sep 25, 2015·Der Urologe. Ausg. A·V Lent, M Schultheis
Oct 2, 2015·European Journal of Cancer Care·L G GordonS K Chambers
Apr 9, 2016·Journal of Occupational and Environmental Medicine·John A RizzoJohn R Penrod
Oct 22, 2016·Journal of the National Cancer Institute·Cheryl K AlticeK Robin Yabroff
Mar 14, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Veena ShankaranScott D Ramsey
Mar 23, 2019·Journal of Cancer Survivorship : Research and Practice·Vanette McLennanMark Frydenberg
Jan 15, 2020·Health Economics Review·Tae-Young PakKyoung Tae Kim
Dec 4, 2019·Nature Reviews. Urology·Brandon S ImberDaniel Gorovets
Feb 11, 2021·JCO Oncology Practice·Sachiko M OshimaLaura J Fish
Mar 2, 2013·Current Opinion in Urology·Marc A Dall'Era
Nov 24, 2020·International Journal of Radiation Oncology, Biology, Physics·Nolan A WagesTimothy N Showalter
Apr 4, 2021·Current Oncology·Nicolas IragorriBeverley Essue
Apr 10, 2021·Nature Reviews. Urology·Sean F MungovanManish I Patel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Benjamin D SmithThomas A Buchholz
American Journal of Public Health
Craig Evan Pollack, Julia Lynch
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Robin MatsuyamaThomas J Smith
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Neal J MeropolAmerican Society of Clinical Oncology
© 2021 Meta ULC. All rights reserved